Apidra® is a rapid-acting prandial insulin for control of hyperglycemia in type 1 or type 2 diabetes. Should be given within 15 minutes before a meal or within 20 minutes after starting a meal. Intended for subcutaneous administration and for use by external infusion pump; dosage should be individualized and determined based on physician's advice in accordance with patient's needs. Active Ingredients: Per ml: 3.49mg insulin glulisine, 3.15mg m-cresol, 6mg tromethamine, 5mg sodium chloride, 0.01mg polysorbate 20 and water for injection.
Product Category:
InsulinSub-category:
Rapid-Acting: InjectedProduct Features:
- Contact manufacturer for further details
Other Features:
How Supplied/Sizing:
100 units per ml. Vial: 10ml. Cartridge: 3ml; 5 per package.
Company information:
Sanofi [1]
- Street:
- 55 Corporate Dr.
- City:
- Bridgewater ,
- Province:
- New Jersey
- Postal Code:
- 08807
- Country:
- United States
Sanofi is part of a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people's lives.
Website:
www.sanofi-aventis.us
Toll free:
1-800-981-2491